Peter Atadja
Peter Atadja" alt="Peter Atadja" itemprop="image">
Company: K36 Therapeutics
Job title: Scientific Co-Founder
Seminars:
PANEL DISCUSSION: 2022 & Beyond: Where Do We See the Epigenetics Drug Discovery & Development Landscape Over the Next 5 Years? 9:00 am
Outlining the successes of the past year in epigenetics drug development Reviewing novel approaches to targeting epigenetic regulators to diversify your pipeline Shedding light on the need to explore novel translational applications for epigenetic drugs to enter new indicationsRead more
day: Day One